Cas no 877133-54-5 (4-Bromo-2,6-diethylpyridine)

4-Bromo-2,6-diethylpyridine structure
4-Bromo-2,6-diethylpyridine structure
Product Name:4-Bromo-2,6-diethylpyridine
CAS No:877133-54-5
MF:C9H12BrN
MW:214.102281570435
MDL:MFCD12755732
CID:706706
PubChem ID:45489869
Update Time:2024-10-26

4-Bromo-2,6-diethylpyridine Chemical and Physical Properties

Names and Identifiers

    • 4-Bromo-2,6-diethylpyridine
    • 4-Bromo-2,6-diethyl-pyridine
    • Pyridine, 4-bromo-2,6-diethyl-
    • Pyridine,4-bromo-2,6-diethyl
    • Pyridine,4-bromo-2,6-diethyl-
    • QAIRPCMWTLMPCW-UHFFFAOYSA-N
    • 3942AC
    • SB21427
    • FCH1346944
    • VP15071
    • AM804469
    • AX8160921
    • 133B545
    • 4-Bromo-2,6-diethylpyridine (ACI)
    • SCHEMBL1465727
    • EN300-7370290
    • DS-12771
    • AC-26915
    • AKOS015842951
    • J-514610
    • DTXSID80670487
    • MFCD12755732
    • DB-010133
    • 877133-54-5
    • CS-0152533
    • MDL: MFCD12755732
    • Inchi: 1S/C9H12BrN/c1-3-8-5-7(10)6-9(4-2)11-8/h5-6H,3-4H2,1-2H3
    • InChI Key: QAIRPCMWTLMPCW-UHFFFAOYSA-N
    • SMILES: BrC1C=C(CC)N=C(CC)C=1

Computed Properties

  • Exact Mass: 213.01500
  • Monoisotopic Mass: 213.015
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 1
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 2
  • Complexity: 104
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 12.9
  • XLogP3: 3.2

Experimental Properties

  • Density: 1.301
  • Boiling Point: 243 °C at 760 mmHg
  • Flash Point: 243 °C at 760 mmHg
  • Refractive Index: 1.534
  • PSA: 12.89000
  • LogP: 2.96890

4-Bromo-2,6-diethylpyridine Customs Data

  • HS CODE:2933399090
  • Customs Data:

    China Customs Code:

    2933399090

    Overview:

    2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-Bromo-2,6-diethylpyridine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Fluorochem
225260-250mg
4-Bromo-2,6-diethylpyridine
877133-54-5 95%
250mg
£59.00 2022-02-28
Fluorochem
225260-1g
4-Bromo-2,6-diethylpyridine
877133-54-5 95%
1g
£147.00 2022-02-28
Fluorochem
225260-5g
4-Bromo-2,6-diethylpyridine
877133-54-5 95%
5g
£440.00 2022-02-28
Alichem
A029185568-1g
4-Bromo-2,6-diethylpyridine
877133-54-5 95%
1g
$278.78 2023-08-31
Alichem
A029185568-5g
4-Bromo-2,6-diethylpyridine
877133-54-5 95%
5g
$828.45 2023-08-31
TRC
B679215-100mg
4-Bromo-2,6-diethylpyridine
877133-54-5
100mg
$ 98.00 2023-04-18
TRC
B679215-250mg
4-Bromo-2,6-diethylpyridine
877133-54-5
250mg
$ 184.00 2023-04-18
TRC
B679215-500mg
4-Bromo-2,6-diethylpyridine
877133-54-5
500mg
$ 293.00 2023-04-18
TRC
B679215-1g
4-Bromo-2,6-diethylpyridine
877133-54-5
1g
$ 375.00 2022-06-06
CHENG DOU FEI BO YI YAO Technology Co., Ltd.
ARK-09357-25g
4-BROMO-2,6-DIETHYL-PYRIDINE
877133-54-5 95%
25g
$1655 2023-09-07

4-Bromo-2,6-diethylpyridine Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Pentabromophosphorane Solvents: Chloroform ;  1 h, 60 °C
1.2 8 h, 120 °C; cooled
1.3 Reagents: Sodium hydroxide Solvents: Water
Reference
Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor
Li, Hui; et al, Journal of Medicinal Chemistry, 2009, 52(5), 1255-1258

Production Method 2

Reaction Conditions
1.1 Reagents: Phosphorus tribromide Solvents: Dichloromethane
Reference
Synthetic route optimization of PF-00868554, an HCV polymerase inhibitor in clinical evaluation
Johnson, Sarah; et al, Synlett, 2010, (5), 796-800

Production Method 3

Reaction Conditions
1.1 Reagents: Phosphoric tribromide Solvents: Dimethylformamide ;  120 °C
Reference
Synthetic route optimization of PF-00868554, an HCV polymerase inhibitor in clinical evaluation
Johnson, Sarah; et al, Synlett, 2010, (5), 796-800

Production Method 4

Reaction Conditions
1.1 Reagents: Phosphoric tribromide ;  90 min, 130 °C
Reference
Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors
Malamas, Michael S.; et al, Bioorganic & Medicinal Chemistry, 2010, 18(2), 630-639

Production Method 5

Reaction Conditions
1.1 Reagents: Sulfuric acid ;  100 °C
1.2 Reagents: Acetic acid ,  Sodium bicarbonate Solvents: Water ;  100 °C; 100 °C → rt
1.3 Reagents: Chloroform ;  reflux
1.4 Reagents: Ammonia Solvents: Water ;  50 °C
1.5 Reagents: Pentabromophosphorane ;  120 °C
Reference
A New Fluorogenic Small-Molecule Labeling Tool for Surface Diffusion Analysis and Advanced Fluorescence Imaging of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Based on Silicone Rhodamine: SiR-BACE1
Karch, Sandra ; et al, Journal of Medicinal Chemistry, 2018, 61(14), 6121-6139

Production Method 6

Reaction Conditions
1.1 Reagents: Sulfuric acid ;  100 °C
1.2 Reagents: Sodium sulfate ;  100 °C
1.3 Reagents: Hydrochloric acid ;  100 °C
1.4 Reagents: Ammonium hydroxide ;  50 °C
2.1 Reagents: Phosphoric tribromide Solvents: Dimethylformamide ;  120 °C
Reference
Synthetic route optimization of PF-00868554, an HCV polymerase inhibitor in clinical evaluation
Johnson, Sarah; et al, Synlett, 2010, (5), 796-800

Production Method 7

Reaction Conditions
1.1 Reagents: Sulfuric acid
1.2 Reagents: Acetic acid ,  Sodium carbonate
1.3 Reagents: Hydrochloric acid
2.1 Reagents: Ammonium hydroxide
2.2 Reagents: Methyl iodide ,  Lithium diisopropylamide Solvents: Tetrahydrofuran
3.1 Reagents: Phosphoric tribromide ;  90 min, 130 °C
Reference
Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors
Malamas, Michael S.; et al, Bioorganic & Medicinal Chemistry, 2010, 18(2), 630-639

Production Method 8

Reaction Conditions
1.1 Reagents: Sulfuric acid ,  Nitric acid
2.1 Reagents: Acetyl bromide Solvents: Acetic acid
3.1 Reagents: Phosphorus tribromide Solvents: Dichloromethane
Reference
Synthetic route optimization of PF-00868554, an HCV polymerase inhibitor in clinical evaluation
Johnson, Sarah; et al, Synlett, 2010, (5), 796-800

Production Method 9

Reaction Conditions
1.1 Reagents: Ammonium hydroxide
1.2 Reagents: Methyl iodide ,  Lithium diisopropylamide Solvents: Tetrahydrofuran
2.1 Reagents: Phosphoric tribromide ;  90 min, 130 °C
Reference
Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors
Malamas, Michael S.; et al, Bioorganic & Medicinal Chemistry, 2010, 18(2), 630-639

Production Method 10

Reaction Conditions
1.1 Reagents: Ammonia Solvents: Water ;  overnight, 50 °C; 50 °C → rt
2.1 Reagents: Pentabromophosphorane Solvents: Chloroform ;  1 h, 60 °C
2.2 8 h, 120 °C; cooled
2.3 Reagents: Sodium hydroxide Solvents: Water
Reference
Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor
Li, Hui; et al, Journal of Medicinal Chemistry, 2009, 52(5), 1255-1258

Production Method 11

Reaction Conditions
1.1 Reagents: Acetyl bromide Solvents: Acetic acid
2.1 Reagents: Phosphorus tribromide Solvents: Dichloromethane
Reference
Synthetic route optimization of PF-00868554, an HCV polymerase inhibitor in clinical evaluation
Johnson, Sarah; et al, Synlett, 2010, (5), 796-800

Production Method 12

Reaction Conditions
1.1 Reagents: m-Chloroperbenzoic acid Solvents: Chloroform
2.1 Reagents: Sulfuric acid ,  Nitric acid
3.1 Reagents: Acetyl bromide Solvents: Acetic acid
4.1 Reagents: Phosphorus tribromide Solvents: Dichloromethane
Reference
Synthetic route optimization of PF-00868554, an HCV polymerase inhibitor in clinical evaluation
Johnson, Sarah; et al, Synlett, 2010, (5), 796-800

Production Method 13

Reaction Conditions
1.1 Catalysts: Dichloro[1,1′-(1,3-propanediyl)bis[1,1-diphenylphosphine-κP]]nickel Solvents: Diethyl ether
2.1 Reagents: m-Chloroperbenzoic acid Solvents: Chloroform
3.1 Reagents: Sulfuric acid ,  Nitric acid
4.1 Reagents: Acetyl bromide Solvents: Acetic acid
5.1 Reagents: Phosphorus tribromide Solvents: Dichloromethane
Reference
Synthetic route optimization of PF-00868554, an HCV polymerase inhibitor in clinical evaluation
Johnson, Sarah; et al, Synlett, 2010, (5), 796-800

4-Bromo-2,6-diethylpyridine Raw materials

4-Bromo-2,6-diethylpyridine Preparation Products

Recommended suppliers
Shanghai Bent Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Shenzhen Yaoyuan R&D Center Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shenzhen Yaoyuan R&D Center Co.,Ltd
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk